Biopharmaceutical industries necessitate exacting technologies and fulfilled regulations for monoclonal antibodies. Shanghai Ritai systems offer a service optimizing all steps of monoclonal antibody production. Based on the principles of high yield and the lowest risks to safety, our systems maximize high yield and high purity in monoclonal antibodies production. We understand the challenges our clients face in various cultures and regulatory frameworks. Our global expertise allows us deliver solutions to accommodate the greatest variety of concerns.
Copyright © 2026 by Shanghai Ritai Medicine Equipment Project Co., Ltd. - Privacy policy